Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ibrahim Al Bakir

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Intestinal Failure (New York, N.Y.)|February 6, 2026
Pilot study of a topical magnesium preparation to treat hypomagnesaemia in patients with an ileostomyJeremy Nightingale, Ibrahim Al Bakir, Franklin Adaba
Frontiers in Immunology|November 3, 2018
From Colitis to Cancer: An Evolutionary Trajectory That Merges Maths and BiologyIbrahim Al Bakir, Kit Curtius, Trevor A Graham
United European Gastroenterology Journal|November 9, 2022
Optimising inflammatory bowel disease surveillance and dysplasia management-Where do we stand?Ibrahim Al Bakir, Misha Kabir, Mehmet Yalchin, et al.
ISRN Surgery|July 11, 2012
Appropriate patient selection in the management of common bile duct stones: when not to do ERCPPalak Jitendrakumar Trivedi, Donald Tse, Ibrahim Al-Bakir, et al.
BMJ Open|October 24, 2019
Mainstreaming of genomic medicine in gastroenterology, present and future: a nationwide survey of UK gastroenterology traineesIbrahim Al Bakir, Gregory Malcolm Sebepos-Rogers, Hilary Burton, et al.
Endoscopy International Open|December 31, 2015
Early clinical experience of the safety and efficacy of EndoClot in the management of non-variceal upper gastrointestinal bleedingSabina Beg, Ibrahim Al-Bakir, Meha Bhuva, et al.
Nature Reviews. Gastroenterology & Hepatology|February 9, 2017
Clonal evolution of colorectal cancer in IBDChang-Ho R Choi, Ibrahim Al Bakir, Ailsa L Hart, et al.
Nature Communications|September 6, 2022
The mutational signatures of formalin fixation on the human genomeQingli Guo, Eszter Lakatos, Ibrahim Al Bakir, et al.
Journal of Clinical Pharmacology|February 12, 2010
Pharmacokinetics and antibody responses to the CD3 antibody otelixizumab used in the treatment of type 1 diabetesGeoff Hale, Peppy Rebello, Ibrahim Al Bakir, et al.
Journal of Crohn'S & Colitis|March 24, 2022
Systematic Review: The Impact and Importance of Body Composition in Inflammatory Bowel DiseaseNik Sheng Ding, Daniel Tassone, Ibrahim Al Bakir, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Intestinal Failure (New York, N.Y.)|February 6, 2026
Pilot study of a topical magnesium preparation to treat hypomagnesaemia in patients with an ileostomyJeremy Nightingale, Ibrahim Al Bakir, Franklin Adaba
Frontiers in Immunology|November 3, 2018
From Colitis to Cancer: An Evolutionary Trajectory That Merges Maths and BiologyIbrahim Al Bakir, Kit Curtius, Trevor A Graham
United European Gastroenterology Journal|November 9, 2022
Optimising inflammatory bowel disease surveillance and dysplasia management-Where do we stand?Ibrahim Al Bakir, Misha Kabir, Mehmet Yalchin, et al.
ISRN Surgery|July 11, 2012
Appropriate patient selection in the management of common bile duct stones: when not to do ERCPPalak Jitendrakumar Trivedi, Donald Tse, Ibrahim Al-Bakir, et al.
BMJ Open|October 24, 2019
Mainstreaming of genomic medicine in gastroenterology, present and future: a nationwide survey of UK gastroenterology traineesIbrahim Al Bakir, Gregory Malcolm Sebepos-Rogers, Hilary Burton, et al.
Endoscopy International Open|December 31, 2015
Early clinical experience of the safety and efficacy of EndoClot in the management of non-variceal upper gastrointestinal bleedingSabina Beg, Ibrahim Al-Bakir, Meha Bhuva, et al.
Nature Reviews. Gastroenterology & Hepatology|February 9, 2017
Clonal evolution of colorectal cancer in IBDChang-Ho R Choi, Ibrahim Al Bakir, Ailsa L Hart, et al.
Nature Communications|September 6, 2022
The mutational signatures of formalin fixation on the human genomeQingli Guo, Eszter Lakatos, Ibrahim Al Bakir, et al.
Journal of Clinical Pharmacology|February 12, 2010
Pharmacokinetics and antibody responses to the CD3 antibody otelixizumab used in the treatment of type 1 diabetesGeoff Hale, Peppy Rebello, Ibrahim Al Bakir, et al.
Journal of Crohn'S & Colitis|March 24, 2022
Systematic Review: The Impact and Importance of Body Composition in Inflammatory Bowel DiseaseNik Sheng Ding, Daniel Tassone, Ibrahim Al Bakir, et al.
Pageof 2